Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Factors associated with outcomes in organophosphate and carbamate poisoning: a retrospective study

  • 7 Accesses

Abstract

Organophosphate and carbamate (OPC) poisoning is a major global health hazard requiring immediate medical intervention. Atropine (ATR) is an essential antidote in organophosphate and carbamate poisoning, with the inclusion of cholinesterase reactivators and other anticholinergics, namely pralidoxime (PAM) and glycopyrrolate (GPR). This study aimed to compare the efficacy of various treatment regimens and identify the factors affecting mortality. The data of patients presented at the emergency unit with the consumption of OPC compounds between the years 2013 and 2017 were retrospectively reviewed. The study population was then categorized into four treatment patterns (1) ATR alone, (2) ATR and PAM, (3) ATR and GPR, (4) ATR, PAM and GPR. The outcome of the patients was assessed in terms of survival, intubation, ICU days, and days of ventilation and hospitalization. Univariate and multivariate analyses were performed to investigate the risk factors associated with mortality and odds ratio (OR). A total of 441 patients were included in the study, of which 69.16% were males, and 375 patients survived. Consumption of poison with a suicidal intention was reported in 98.19% of the patients, and the treatment with ATR and PAM (42.86%) was observed to have lower days of ventilation in comparison to the treatment with ATR and GPR (p = 0.003). Patients requiring intubation were also lowest in the group treated with ATR and PAM (27.51%). The age group of > 50 years (OR 4.275 [CI 2.179–8.387]), male gender (OR 2.608 [CI 1.258–5.406]), and the treatment pattern with ATR, PAM and GPR (OR 2.233 [CI 1.002–4.040]) were independently associated with mortality. In summary, male gender, elderly population, and treatment patterns followed adversely affected the outcome in patients with OPC poisoning.

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Palaniappen V (2013) Current concepts in the management of organophosphorus compound poisoning Medicine update. The Association of Physician of India, Mumbai, pp 427–433

  2. 2.

    Singh S, Sharma N (2000) Neurological syndromes following organophosphate poisoning. Neurol India 48:308–313

  3. 3.

    Eddleston M, Buckley NA, Eyer P, Dawson AH (2008) Management of acute organophosphorus pesticide poisoning. Lancet 371:597–607

  4. 4.

    Karalliedde L, Senanayake N (1989) Organophosphorous insecticide poisoning. Br J Anaesth 63:736–750

  5. 5.

    Sanz P, Rodriguez-vicente MC, Diaz D, Repetto J, Repetto M (1991) Red blood cell and total blood acetylcholinesterase and plasma pseudocholinesterase in humans: observed variances. J Toxicol Clin Toxicol 29:81–90

  6. 6.

    Rajapakse BN, Thiermann H, Eyer P, Worek F, Bowe SJ, Dawson AH, Buckley NA (2011) Evaluation of the test-mate ChE (cholinesterase) field kit in acute organophosphorus poisoning. Ann Emerg Med 58:559–564

  7. 7.

    Eddleston M, Buckley NA, Checketts H, Senarathna L, Mohamed F, Sheriff MHR, Dawson A (2004) Speed of initial atropinisation in significant organophosphorus pesticide poisoning—a systematic comparison of recommended regimens. J Toxicol Clin Toxicol 42:865–875

  8. 8.

    Kumaraswamy RC, Madhavi KMS, Basavanthappa SP, Gowda MRN (2014) Open-label randomized controlled study comparing continuous infusion versus intermittent bolus dose of atropine with or without pralidoxime in the treatment of organophosphorus poisoning in a teaching hospital. SMJ 17:3–6

  9. 9.

    Rosman Y, Makarovsky I, Bentur Y, Shrot S, Dushnistky T, Krivoy A (2009) Carbamate poisoning: treatment recommendations in the setting of a mass casualties event. Am J Emerg Med 27:1117–1124

  10. 10.

    Mirakhur RK, Dundee JW (1983) Glycopyrrolate: pharmacology and clinical use. Anaesthesia 38:1195–1204

  11. 11.

    Arendse R, Irusen E (2009) An atropine and glycopyrrolate combination reduces mortality in organophosphate poisoning. Hum Exp Toxicol 28:715–720

  12. 12.

    Bardin PG, Van Eeden SF, Joubert JR (1987) Intensive care management of acute organophosphate poisoning. A 7-year experience in the Western Cape. South Afr Med J 72:593–597

  13. 13.

    Bhandarkar AA (2014) Efficacy of atropine alone and with glycopyrrolate combination in organophosphate poisoning. Value Health 17:A750–A751

  14. 14.

    Schmidt E, Gerhardt W, Henkel E, Klauke R, Liese W, Lorentz K, Sonntag O, Stein W, Weidemann G (1992) Proposal of standard methods for the determination of enzyme catalytic concentrations in serum and plasma at 37 °C. Clin Chem Lab Med 30:247–256

  15. 15.

    Poisoning Severity Score (PSS) IPCS/EAPCCT. https://www.who.int/ipcs/poisons/pss.pdf/. Accessed 30 Mar 2019

  16. 16.

    Banday TH, Tathineni B, Desai MS, Naik V (2015) Predictors of morbidity and mortality in organophosphorus poisoning: a case study in rural hospital in Karnataka, India. N Am J Med Sci 7:259–265

  17. 17.

    Kumar Mr, Vignan Kumar G, Kumar Ss, Subrahmanyam B, Veeraprasad M, Rammohan P, Srinivas M, Babu Pr, Agrawal A (2014) A retrospective analysis of acute organophosphorus poisoning cases admitted to the tertiary care teaching hospital in South India. Ann Afr Med 13:71

  18. 18.

    Kar N (2006) Lethality of suicidal organophosphorus poisoning in an Indian population: exploring preventability. Ann Gen Psychiatry 5:1–5

  19. 19.

    Somasundaram KV, Patil A, Shukla S (2009) Epidemiological Profile of OP poisoning cases Treated at Pravara Hospital, Loni, India. Indian J Prev Soc Med 40:184–188

  20. 20.

    Gupta P, Honnungar RS, Pujar SS (2015) Trend of male poisoning at North Karnataka from 2008–2013. J Indian Acad Forensic Med 37:278–280

  21. 21.

    Chintale KN, Patne SV, Chavan SS (2016) Clinical profile of organophosphorus poisoning patients at rural tertiary health care centre. Ind J Adv Med 3:268–272

  22. 22.

    Coskun R, Gundogan K, Sezgin GC, Topaloglu US, Hebbar G, Guven M, Sungur M (2015) A retrospective review of intensive care management of organophosphate insecticide poisoning: single center experience. Niger J Clin Pract 18:644–650

  23. 23.

    Selvaraj T, Sudharson T (2016) Demographic and clinical profile of organophosphorus poisoning cases in a Medical College Hospital, Tamil Nadu. Indian J Forensic Community Med 3:124

  24. 24.

    Eddleston M, Mohamed F, Davies JOJ, Eyer P, Worek F, Sheriff MR, Buckley NA (2007) Respiratory failure in acute organophosphorus pesticide self-poisoning. QJM 99:513–522

  25. 25.

    Rathod AL, Garg RK (2017) Chlorpyrifos poisoning and its implications in human fatal cases: a forensic perspective with reference to Indian scenario. J Forensic Leg Med 47:29–34

  26. 26.

    Gunnell D, Eddleston M, Phillips MR, Konradsen F (2007) The global distribution of fatal pesticide self-poisoning: systematic review. BMC Public Health 7:1–15

  27. 27.

    Almutairi MK, Almoaiqel FA, Alanazi A, Aljerian N, Alqahtani A, Harthy N Al, Qureshi S, Kumar S (2016) A report on the incidence of organophosphate poisoning among patients admitted to King Abdul-Aziz Medical City, Riyadh, Saudi Arabia over a Period of 12 years. Br J Med Med Res 13:1–8

  28. 28.

    Jokanović M (2009) Medical treatment of acute poisoning with organophosphorus and carbamate pesticides. Toxicol Lett 190:107–115

  29. 29.

    Eyer P (2003) The Role of Oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev 22:165–190

  30. 30.

    Syed S, Gurcoo SA, Farooqui AK, Nisa W, Sofi K (2015) Is the World Health Organization-recommended dose of pralidoxime effective in the treatment of organophosphorus poisoning? A randomized, double-blinded and placebo-controlled trial. Saudi J Anaesth 9:49–54

  31. 31.

    Worek F, Bäcker M, Thiermann H, Szinicz L, Mast U, Klimmek R, Eyer P (1997) Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum Exp Toxicol 16:466–472

  32. 32.

    Kurtz PH (1990) Pralidoxime in the treatment of carbamate intoxication. Am J Emerg Med 8:68–70

  33. 33.

    Singh S, Chaudhry D, Behera D, Gupta D, Jindal S (2001) Aggressive atropinisation and continuous pralidoxime (2-PAM) infusion in patients with severe organophosphate. Hum Exp Toxicol 20:15–18

  34. 34.

    Ahmed SM, Das B, Nadeem A, Samal RK (2014) Survival pattern in patients with acute organophosphate poisoning on mechanical ventilation: a retrospective intensive care unit-based study in a tertiary care teaching hospital. Indian J Anaesth 58:11–17

  35. 35.

    Mahesh M, Gowdar M, Venkatesh CR (2013) A study on two dose regimens of pralidoxime in the management of organophosphate poisoning. Asia Pac J Med Toxicol 2:121–125

  36. 36.

    Pawar KS, Bhoite RR, Pillay CP, Chavan SC, Malshikare DS, Garad SG (2006) Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomised controlled trial. Lancet 368:2136–2141

  37. 37.

    Baloch GH, Khan AH, Madhudas C, Devrajani BR, Shah SZ, Das T, Shah SF (2018) Outcome of acute organophosphorus poisoning at Liaquat University Hospital Hyderabad. World Appl Sci J 13:266–268

  38. 38.

    Banerjee I, Roy As, Tripathi S (2014) Efficacy of pralidoxime in organophosphorus poisoning: revisiting the controversy in Indian setting. J Postgrad Med 60:27

  39. 39.

    Kamal SM, Akhter S, Ahmed SFU, Chowdhury PK, Rashid A (2017) Outcome of treatment of OPC poisoning patients with atropine or atropine plus pralidoxime. Bang Med J Khulna 50:3–7

  40. 40.

    Roberts DM, Aaron CK (2008) Managing acute organophosphorus pesticide poisoning. Br Med J 334:629–634

  41. 41.

    Cherian AM, Peter JV, Samuel J, Jaydevan R, Peter S, Joel S, Jeyasselan L, Thomas K (1997) Effectiveness of P2AM (PAM -pralidoxime) in the treatment of organophosphorus poisoning. A randomised, double blind placebo controlled trial. J Assoc Physicians India 45:22–24

  42. 42.

    Rahimi R, Nikfar S, Abdollahi M (2006) Increased morbidity and mortality in acute human organophosphate-poisoned patients treated by oximes: a meta-analysis of clinical trials. Hum Exp Toxicol 25:157–162

  43. 43.

    Choi PT, Quinonez LG, Cook DJ, Baxter F, Whitehead L (1998) The use of glycopyrrolate in a case of intermediate syndrome following acute organophosphate poisoning. Can J Anaesth 45:337–340

  44. 44.

    Ramesh Unnikrishnan AS (2012) Clinical outcomes of patients admitted with organophosphorus poisoning in a tertiary hospital in Udupi district Indian. J Respir Care 1:59–65

  45. 45.

    Anju N, Nalini P (2010) Comparison of efficacy and safety of atropine sulphate and glycopyrrolate in the treatment of organophosphorus poisoning at St. Martha’s Hospital, Bangalore. Indian J Pharm Pract 3:43–46

  46. 46.

    Chaudhary S, Jain N, Atam V, Agarwal A, Singh K, Sawlani K, Vaish A, Patel M (2013) Prognostic significance of estimation of pseudocholinesterase activity and role of pralidoxime therapy in organophosphorous poisoning. Toxicol Int 20:214

  47. 47.

    Chugh SN, Aggarwal N, Dabla S, Chhabra B (2005) Comparative evaluation of “atropine alone” and “atropine with pralidoxime (PAM)” in the management of organophosphorus poisoning. J Indian Acad Clin Med 6:33–37

  48. 48.

    Karakus A, Celik MM, Karcioglu M, Tuzcu K, Erden ES, Zeren C (2014) Cases of organophosphate poisoning treated with high-dose of atropine in an intensive care unit and the novel treatment approaches. Toxicol Ind Health 30:421–425

  49. 49.

    Ginsberg G, Hattis D, Russ A, Sonawane B (2005) Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals. Environ Health Perspect 113:1243–1249

  50. 50.

    Moss M, Burnham EL (2006) Alcohol abuse in the critically ill patient. Lancet 368:2231–2242

  51. 51.

    Eddleston M, Gunnell D, Von Meyer L, Eyer P (2009) Relationship between blood alcohol concentration on admission and outcome in dimethoate organophosphorus self-poisoning. Br J Clin Pharmacol 68:916–919

Download references

Acknowledgements

We would like to thank Manipal Academy of Higher Education, Department of Medicine, Kasturba Medical College, Department of Pharmacy practice, Manipal College of Pharmaceutical Sciences, Centre for Toxicovigilance and Drug Safety, and the staff for supporting us during the study. We specially thank Ms.Pooja Poojari for helping us with the submission process.

Funding

The authors declare that they have no funding.

Author information

Correspondence to Girish Thunga.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Reddy, B.S., Skaria, T.G., Polepalli, S. et al. Factors associated with outcomes in organophosphate and carbamate poisoning: a retrospective study. Toxicol Res. (2020). https://doi.org/10.1007/s43188-019-00029-x

Download citation

Keywords

  • Atropine
  • Carbamate
  • Glycopyrrolate
  • Organophosphate
  • Older age
  • Pralidoxime